Increased inflammatory activity could potentially lead to exaggerated responses to inflammatory insults to the airways, and plasma YKL-40 may be a new prognostic biomarker in patients with COPD. The gene discussed is CHI3L1; the disease is chronic obstructive pulmonary disease.